|
Status |
Public on Nov 29, 2019 |
Title |
P3_TGF-β1_0h |
Sample type |
RNA |
|
|
Source name |
dermal fibroblasts
|
Organism |
Homo sapiens |
Characteristics |
cell type: dermal fibroblasts disease state: patient with chronic mucocutaneous candidiasis and connective tissue disorder mutation: MAPK8 c.311+1G>A treatment: untreated
|
Treatment protocol |
Cells were left untreated or treated for 2, 6, or 24 hours with TGF-β1 (10 ng/ml)
|
Growth protocol |
Dermal fibroblasts were cultured in DMEM supplemented with 10% FBS
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted with the RNeasy Plus Micro Kit from QIAGEN
|
Label |
biotin
|
Label protocol |
Standard Affymetrix protocol
|
|
|
Hybridization protocol |
Standard Affymetrix protocol
|
Scan protocol |
Standard Affymetrix protocol
|
Data processing |
The data were analyzed with R with RMA normalization
|
|
|
Submission date |
Sep 09, 2019 |
Last update date |
Nov 30, 2019 |
Contact name |
Tanwir Habib |
E-mail(s) |
thabib@sidra.org
|
Organization name |
Sidra Medicine
|
Street address |
Al Luqta Street
|
City |
Doha |
ZIP/Postal code |
26999 |
Country |
Qatar |
|
|
Platform ID |
GPL16686 |
Series (2) |
GSE137107 |
Human JNK1 haploinsufficiency: a novel genetic etiology of chronic mucocutaneous candidiasis and connective tissue disorder |
GSE137110 |
Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A/F and TGF-? |
|